Following a turbulent period, there has been a notable change in the trajectory of biotech stocks. After experiencing significant downturns in 2021 and 2022, the$SPDR S&P Biotech ETF (XBI.US)$has seen an increase of 5.5% in the current year. However, it continues to trail considerably behind the$S&P 500 Index (.SPX.US)$, which has achieved a 24% gain. However, analysts indicate that the previously cool sent...
$ArcBest (ARCB.US)$initiated at buy by Jefferies, announced target price at $110.00. $Saia (SAIA.US)$initiated at buy by Jefferies, announced targe price at $350.00. $AutoZone (AZO.US)$was upgraded by Evercore ISI Group from in-line to outperform, increased target price to $2700.00. $Oracle (ORCL.US)$was upgraded by Wolfe Research from peer perform to outperform, increased target price to $130.00. $BILL Holdings (BILL.US)$was downg...
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual